| Primary |
| Atrial Fibrillation |
43.4% |
| Product Used For Unknown Indication |
16.3% |
| Arrhythmia |
11.4% |
| Drug Use For Unknown Indication |
7.2% |
| Unevaluable Event |
3.6% |
| Hypertension |
2.4% |
| Cardiac Disorder |
1.8% |
| Supraventricular Tachycardia |
1.8% |
| Arrhythmia Prophylaxis |
1.2% |
| Atrial Flutter |
1.2% |
| Atrial Tachycardia |
1.2% |
| Diabetes Mellitus |
1.2% |
| Extrasystoles |
1.2% |
| Heart Rate Irregular |
1.2% |
| Investigation |
1.2% |
| Palpitations |
1.2% |
| Anxiety |
0.6% |
| Blood Cholesterol |
0.6% |
| Breast Cancer |
0.6% |
| Dementia Alzheimer's Type |
0.6% |
|
| Product Quality Issue |
14.1% |
| Vomiting |
14.1% |
| Completed Suicide |
7.0% |
| Drug Ineffective |
7.0% |
| Pruritus |
5.6% |
| Tachycardia |
5.6% |
| Ventricular Extrasystoles |
5.6% |
| Accidental Exposure |
4.2% |
| Heart Rate Irregular |
4.2% |
| Ventricular Fibrillation |
4.2% |
| Atrioventricular Block Second Degree |
2.8% |
| Dyspnoea |
2.8% |
| Grand Mal Convulsion |
2.8% |
| Heart Rate Increased |
2.8% |
| Hypotension |
2.8% |
| Nausea |
2.8% |
| Neoplasm Malignant |
2.8% |
| Palpitations |
2.8% |
| Pulmonary Congestion |
2.8% |
| Therapeutic Agent Toxicity |
2.8% |
|
| Secondary |
| Atrial Fibrillation |
36.7% |
| Product Used For Unknown Indication |
18.0% |
| Hypertension |
12.5% |
| Arrhythmia |
10.2% |
| Atrial Flutter |
4.7% |
| Ventricular Tachycardia |
3.1% |
| Dyslipidaemia |
2.3% |
| Heart Rate Irregular |
1.6% |
| Hypothyroidism |
1.6% |
| Osteoporosis |
1.6% |
| Supraventricular Tachycardia |
1.6% |
| Cardiac Fibrillation |
0.8% |
| Cataract Operation |
0.8% |
| Coronary Artery Disease |
0.8% |
| Depression |
0.8% |
| Hypertonic Bladder |
0.8% |
| Menopausal Disorder |
0.8% |
| Palpitations |
0.8% |
| Thrombosis Prophylaxis |
0.8% |
|
| Brugada Syndrome |
9.7% |
| Interstitial Lung Disease |
9.7% |
| Product Quality Issue |
9.7% |
| Drug Ineffective |
6.5% |
| Jaundice |
6.5% |
| Orthostatic Hypotension |
6.5% |
| Product Substitution Issue |
6.5% |
| Vomiting |
6.5% |
| Asthenia |
3.2% |
| Atrial Fibrillation |
3.2% |
| Biliary Colic |
3.2% |
| Blood Pressure Inadequately Controlled |
3.2% |
| Blood Pressure Systolic Increased |
3.2% |
| Bradyarrhythmia |
3.2% |
| Cardiac Disorder |
3.2% |
| Cardiac Failure Congestive |
3.2% |
| Cholestasis |
3.2% |
| Heart Rate Decreased |
3.2% |
| Hepatocellular Injury |
3.2% |
| Hyperkalaemia |
3.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
28.4% |
| Hypertension |
14.7% |
| Drug Use For Unknown Indication |
12.3% |
| Atrial Fibrillation |
9.6% |
| Prophylaxis |
4.6% |
| Rheumatoid Arthritis |
3.4% |
| Diabetes Mellitus |
2.9% |
| Osteoporosis |
2.6% |
| Blood Cholesterol Increased |
2.4% |
| Hypercholesterolaemia |
2.4% |
| Arrhythmia |
2.2% |
| Breast Cancer |
2.2% |
| Asthma |
1.9% |
| Insomnia |
1.9% |
| Arthritis |
1.4% |
| Coronary Artery Bypass |
1.4% |
| Dyslipidaemia |
1.4% |
| Non-small Cell Lung Cancer Stage Iii |
1.4% |
| Pain |
1.4% |
| Renal Cell Carcinoma |
1.4% |
|
| Atrial Fibrillation |
8.2% |
| Myocardial Infarction |
8.2% |
| Pneumonia |
8.2% |
| Somnolence |
8.2% |
| Hypotension |
6.6% |
| Nausea |
6.6% |
| Palpitations |
6.6% |
| Drug Interaction |
4.9% |
| Transient Global Amnesia |
4.9% |
| Ventricular Extrasystoles |
4.9% |
| Alopecia |
3.3% |
| Anaemia |
3.3% |
| Balance Disorder |
3.3% |
| Blood Pressure Increased |
3.3% |
| Bradycardia |
3.3% |
| Bronchiectasis |
3.3% |
| Demyelinating Polyneuropathy |
3.3% |
| Erythema |
3.3% |
| Ischaemic Stroke |
3.3% |
| Lymphocyte Percentage Decreased |
3.3% |
|
